文献速递流行病学与生物统计真实世界研究与卫生经济

慢性阻塞性肺疾病临床试验数据库的构建:设计、实施与应用

Development of a database for investigating characteristics and quality of published clinical trials in chronic obstructive pulmonary disease: design, implementation, and application.
PubMed 文献 · Trials · 2026-07-27

本研究采用个体文献检索与元流行病学相结合的策略,系统检索截至2023年6月30日发表的COPD临床试验报告。英文文献筛选完成,合并检索结果后重复率为61.6%,最终纳入2261篇原始试验报告,主要涉及药物治疗和肺康复。研究初步建立了结构化、人工管理的COPD临床试验数据库,并显示双轨检索策略优于单一检索。

要点

  • 双轨检索策略(个体检索+元流行病学)可提高文献查全率,重复率61.6%。
  • 纳入2261篇英文COPD临床试验报告,药物治疗占48.1%,肺康复占26.8%。
  • 数据库将转为开放获取平台并持续更新,支持二次研究。

核心结论

  • 初步建立了包含2261篇英文COPD临床试验的结构化、人工管理数据库。
  • 双轨检索策略在全面性上优于单一检索方法。

研究设计与样本

  • 采用个体文献检索与元流行病学相结合的策略,系统检索截至2023年6月30日发表的原始临床试验报告。
  • 数据来源包括PubMed、Cochrane Library、CNKI、VIP、万方和CBM数据库。
  • 使用CONSORT报告标准提取数据,并采用ROB 2.0评估偏倚风险。

主要发现

  • 检索识别出36127篇英文RCT和142670篇中文RCT,以及4019篇英文和3219篇中文meta分析。
  • 英文文献筛选完成,合并检索结果后重复率为61.6%,最终纳入2261篇原始试验报告。
  • 纳入文献主要关注药物治疗[1087篇(48.1%)]和肺康复[607篇(26.8%)]。
  • 药物治疗研究中,吸入性西药最受关注[684篇(30.3%)],其次为口服西药[299篇(13.2%)]。

临床怎么用

  • 该数据库可为COPD领域的二次研究提供系统整理的数据基础。
  • 未来将转为开放获取平台并持续更新,以支持证据整合与利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the increasing long-term burden of chronic obstructive pulmonary disease (COPD), scientifically rigorous, efficient, and sustainable disease management has become a critical priority. However, the exponential proliferation of publications and the increasing granularity of research topics have amplified the difficulty of retrieving, integrating, and utilizing clinical evidence. Establishing a systematically curated, disease-specific clinical trial database can therefore provide a robust data foundation for diverse secondary research. METHODS: Using a combined strategy of individual-level literature searching and meta-epidemiological approaches, we systematically searched for primary clinical trial reports published before June 30, 2023. The literature data were sourced from PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Database, Wanfang Database, and China Biology Medicine Database (CBM). Trial data were extracted using the CONSORT reporting standards, and the risk of bias in clinical trials was assessed using the ROB 2.0. RESULTS: In the search results, we identified 36,127 English RCTs and 142,670 Chinese RCTs, along with 4019 English meta-analyses and 3219 Chinese meta-analyses. Screening of the English-language literature was completed, and upon merging the two sets of search results, a duplication rate of 61.6% was found, resulting in the inclusion of 2261 primary trial reports. The included literature primarily focused on drug treatment [1087 (48.1%)] and pulmonary rehabilitation studies [607 (26.8%)]. Within drug treatment research, inhaled western medications garnered the most attention [684 (30.3%)], followed by oral western medications [299 (13.2%)]. CONCLUSION: This study preliminarily established a structured, manually curated database comprising 2261 English-language COPD clinical trials. Currently, the repository provides a preliminary stratification of these trials and illustrates the superior comprehensiveness of a dual-track retrieval strategy over a single search approach. Moving forward, the database will transition into an open-access research platform and be continuously updated to ensure its comprehensiveness and timeliness.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zhao Y, Zhang P, et al. Development of a database for investigating characteristics and quality of published clinical trials in chronic obstructive pulmonary disease: design, implementation, and application. Trials. 2026. PMID: 42934710. doi:10.1186/s13063-026-09923-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。